What Is The Most Selling Drug In 2025? Keytruda Leads a Dynamic Market
•
4 min read
According to March 2025 projections, Keytruda from Merck & Co. is expected to remain the top pharmaceutical product with an estimated $31 billion in global sales. The race for the title of **What is the most selling drug in 2025?** highlights the ongoing shifts and dominant therapeutic areas in the global pharmaceutical market, led by innovations in cancer treatment and metabolic therapies.
